Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updated to show Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedA new revision label v3.3.1 was added, and the previous v3.2.0 revision was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedRemoved the government funding status notice banner.SummaryDifference0.2%

- Check63 days agoChange DetectedThe new screenshot shows the same version-history list with no substantive changes to the trial record; it appears to be a cosmetic update to the page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded a government funding notice and updated version to v3.2.0; removed reference to v3.1.0.SummaryDifference7%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.